sevelamer

(redirected from Renvela)
Also found in: Medical.
Translations

sevelamer

n sevelámero
References in periodicals archive ?
Amneal Pharmaceuticals LLC has rolled out sevelamer carbonate tablets 800 mg, a generic version of Sanofi's Renvela tablets.
The product is the generic version of the reference listed drug, Genzyme Corporation's Renvela tablets, 800 mg.
Reddys Laboratories Ltd announced today that it has launched Sevelamer Carbonate Tablets, 800 mg, a therapeutic equivalent generic version of Renvela (sevelamer carbonate) Tablets, approved by the U.
Welchol: Daiichi Sankyo Inc, Tokyo, Japan; Colestid: Pfizer Inc, New York, New York; LoCholest: Warner Chilcott Inc, Rockaway, New Jersey; Prevalite: Upsher-Smith Laboratories, Maple Grove, Minnesota; Questran: Par Pharmaceutical, Woodcliff Lake, New Jersey; Kayexalate: Concordia International Corp, Oakville, Ontario, Canada; and Renvela and Renagel: Sanofi SA, Paris, France.
I went to get medications and my Renvela co-pay was normally five dollars.
The oral medicines used by dialysis patients include Amgen's Sensipar and two products from Genzyme, Renagel and Renvela, which cut phosphate levels.
Genzyme Corporation, Cambridge, MA, announced the European Commission (EC) has approved Renvela for the control of serum phosphorus in patients with chronic kidney disease (CKD).
Sevelamer carbonate will be marketed under the trade name Renvela.
M2 PHARMA-October 24, 2017-Impax passes US FDA approval for generic Renvela (sevelamer carbonate) Tablets, 800 mg
M2 EQUITYBITES-October 24, 2017-Impax passes US FDA approval for generic Renvela (sevelamer carbonate) Tablets, 800 mg
The Genzyme Corporation, Cambridge, MA, announced that the European Medicines Agency's Committee for Medicinal Products (CHMP) has adopted a positive opinion for the marketing authorization of the new phosphate binder Renvela for use in patients with chronic kidney disease (CKD), including patients not on dialysis with serum phosphorous levels >1.